As on Wednesday,Lexaria Bioscience Corp (NASDAQ: LEXX) got off with the flyer as it spiked 2.37% to $0.98, before settling in for the price of $0.95 at the close. Taking a more long-term approach, LEXX posted a 52-week range of $0.77-$3.39.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 21.61%. Meanwhile, its Annual Earning per share during the time was 21.61%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -47.87%. This publicly-traded company’s shares outstanding now amounts to $19.46 million. The organization now has a market capitalization sitting at $21.68 million. At the time of writing, stock’s 50-day Moving Average stood at $0.9923, while the 200-day Moving Average is $1.3227.
Lexaria Bioscience Corp (LEXX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Lexaria Bioscience Corp’s current insider ownership accounts for 8.19%, in contrast to 11.75% institutional ownership. According to the most recent insider trade that took place on Jul 29 ’25, this organization’s Director bought 15,600 shares at the rate of 0.92, making the entire transaction reach 14,375 in total value, affecting insider ownership by 270,012. Preceding that transaction, on Jul 30 ’25, Company’s Director bought 11,900 for 0.91, making the whole transaction’s value amount to 10,866. This particular insider is now the holder of 281,912 in total.
Lexaria Bioscience Corp (LEXX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
Lexaria Bioscience Corp’s EPS decrease for this current 12-month fiscal period is -47.87% and is forecasted to reach -0.47 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 6.84% through the next 5 years, which can be compared against the 21.61% growth it accomplished over the previous five years trading on the market.
Lexaria Bioscience Corp (NASDAQ: LEXX) Trading Performance Indicators
Let’s observe the current performance indicators for Lexaria Bioscience Corp (LEXX). It’s Quick Ratio in the last reported quarter now stands at 3.90. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 34.97.
In the same vein, LEXX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.66, a figure that is expected to reach -0.17 in the next quarter, and analysts are predicting that it will be -0.47 at the market close of one year from today.
Technical Analysis of Lexaria Bioscience Corp (LEXX)
Through scrutinizing the latest numbers posted by the [Lexaria Bioscience Corp, LEXX], it can be observed that its last 5-days Average volume of 4.4 million was better the volume of 0.26 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 9.64% While, its Average True Range was 39.91.
Raw Stochastic average of Lexaria Bioscience Corp (LEXX) in the period of the previous 100 days is set at 25.85%, which indicates a major rise in contrast to 14.22% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1655 that was higher than 0.0792 volatility it exhibited in the past 100-days period.
